Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GSK2801 |
Trade Name | |
Synonyms | GSK 2801|GSK-2801 |
Drug Descriptions |
GSK2801 is a bromodomain inhibitor that selectively inhibits BAZ2A/B and BRD9, which has potential antitumor activity (PMID: 31000582). |
DrugClasses | |
CAS Registry Number | 1619994-68-1 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Birabresib + GSK2801 | Birabresib GSK2801 | 0 | 0 |
GSK2801 | GSK2801 | 0 | 0 |
GSK2801 + HY-16462 | GSK2801 HY-16462 | 0 | 0 |
GSK2801 + JQ1 | GSK2801 JQ1 | 0 | 0 |